Lotus Pharmaceutical Co., Ltd. appointed Arni Hardarson as Representative of the Company's Institutional Director in place of Thor Kristjansson. Effective date of the new appointment is March 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
310.5 TWD | +7.07% | +7.63% | +14.15% |
06-13 | Lotus Pharmaceutical Co., Ltd. Announces Audit and Remuneration Committee Changes | CI |
06-13 | Lotus Pharmaceutical Co., Ltd. Announces Board Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.15% | 2.52B | |
+54.61% | 811B | |
+43.62% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+17.94% | 246B | |
+2.54% | 225B | |
+12.68% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Change in Representative of the Company's Institutional Director